1. Home
  2. TOPP vs DTIL Comparison

TOPP vs DTIL Comparison

Compare TOPP & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOPP
  • DTIL
  • Stock Information
  • Founded
  • TOPP 2014
  • DTIL 2006
  • Country
  • TOPP United States
  • DTIL United States
  • Employees
  • TOPP N/A
  • DTIL N/A
  • Industry
  • TOPP
  • DTIL Biotechnology: Pharmaceutical Preparations
  • Sector
  • TOPP
  • DTIL Health Care
  • Exchange
  • TOPP NYSE
  • DTIL Nasdaq
  • Market Cap
  • TOPP 23.1M
  • DTIL 56.2M
  • IPO Year
  • TOPP 2025
  • DTIL 2019
  • Fundamental
  • Price
  • TOPP $1.50
  • DTIL $5.15
  • Analyst Decision
  • TOPP
  • DTIL Strong Buy
  • Analyst Count
  • TOPP 0
  • DTIL 2
  • Target Price
  • TOPP N/A
  • DTIL $47.00
  • AVG Volume (30 Days)
  • TOPP 151.4K
  • DTIL 161.1K
  • Earning Date
  • TOPP 01-01-0001
  • DTIL 05-15-2025
  • Dividend Yield
  • TOPP N/A
  • DTIL N/A
  • EPS Growth
  • TOPP N/A
  • DTIL N/A
  • EPS
  • TOPP 0.01
  • DTIL 1.04
  • Revenue
  • TOPP $16,039,513.00
  • DTIL $68,696,000.00
  • Revenue This Year
  • TOPP N/A
  • DTIL N/A
  • Revenue Next Year
  • TOPP N/A
  • DTIL $30.20
  • P/E Ratio
  • TOPP $125.24
  • DTIL $4.95
  • Revenue Growth
  • TOPP N/A
  • DTIL 40.98
  • 52 Week Low
  • TOPP $0.97
  • DTIL $3.61
  • 52 Week High
  • TOPP $4.50
  • DTIL $13.44
  • Technical
  • Relative Strength Index (RSI)
  • TOPP N/A
  • DTIL 49.18
  • Support Level
  • TOPP N/A
  • DTIL $5.08
  • Resistance Level
  • TOPP N/A
  • DTIL $5.97
  • Average True Range (ATR)
  • TOPP 0.00
  • DTIL 0.36
  • MACD
  • TOPP 0.00
  • DTIL -0.02
  • Stochastic Oscillator
  • TOPP 0.00
  • DTIL 19.61

About TOPP TOPPOINT HOLDINGS INC

Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Share on Social Networks: